🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Mixed amphetamine salts (ADDERALL XR)

    Takeda

    ADHD

    approved small molecule completed

    1 trial

  2. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial

  3. Mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    approved mab completed

    1 trial

  4. Mumps vaccine, Live (MV)

    Sinovac Research and Development Co.,

    Mumps

    approved mab active

    1 trial

  5. Myozyme 50 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease / glycogenosis type II / acid maltase deficiency

    approved small molecule active

    1 trial

  6. Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial

  7. NAC

    United Therapeutics Europe Ltd

    Effects of High Altitude

    approved small molecule terminated

    1 trial

  8. Nafamostat mesilate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sepsis

    approved small molecule active

    1 trial

  9. Naldebain

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule active

    1 trial

  10. Namuscla 167 mg hard capsules, Mexiletine 62 mg hard capsules, Mexiletine 83 mg hard capsules

    Lupin Europe GmbH

    Myotonic disorders: Nondystrophic myotonias (NDM) or myotonic dystrophies (DM, type 1 or type 2)

    approved small molecule active

    1 trial

  11. Neovascular Age-related Macular Degeneration

    Novartis Pharmaceuticals

    Neovacular Age-related Macular Degeneration

    approved other completed

    1 trial

  12. NextDose (nextdose.org)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thrombosis Embolism

    approved other active

    1 trial

  13. Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Glycogen storage disease type II or acid maltase deficiency, Pompe disease

    approved small molecule active

    1 trial

  14. Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Sanofi Winthrop Industrie

    Glycogen storage disease type II

    approved small molecule active

    1 trial

  15. Nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-obstructive Coronary Artery Disease

    approved small molecule terminated

    1 trial

  16. Nicorandil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stable Angina

    approved small molecule completed

    1 trial

  17. Nicorandil 5mg tid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Artery Bypass Graft

    approved small molecule active

    1 trial

  18. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  19. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule terminated

    3 trials

  20. Nicotine patch - transdermal

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  21. Norepinephrine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Septic Shock

    approved small molecule completed

    1 trial

  22. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  23. Normal saline

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

  24. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources